Clinical trials
Phase 1/2 Mesothelioma, Malignant trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
19 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2008 | 1 |
| 2010 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 2 |
| 2019 | 2 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 2 |
| 2024 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 6 |
| Terminated | 5 |
| Active, not recruiting | 4 |
| Completed | 3 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| National Cancer Institute (NCI) | 4 |
| TCR2 Therapeutics | 2 |
| 7 Hills Pharma, LLC | 1 |
| A2 Biotherapeutics Inc. | 1 |
| Aminex Therapeutics, Inc. | 1 |
| CRISPR Therapeutics AG | 1 |
| CanBas Co. Ltd. | 1 |
| Fred Hutchinson Cancer Center | 1 |
| InSilico Medicine Hong Kong Limited | 1 |
| Medicenna Therapeutics, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Mesothelioma, Malignant | 19 |
| Carcinoma, Non-Small-Cell Lung | 9 |
| Colorectal Neoplasms | 5 |
| Ovarian Neoplasms | 5 |
| Carcinoma, Renal Cell | 4 |
| Endometrial Neoplasms | 4 |
| Esophageal Neoplasms | 4 |
| Neoplasms | 4 |
| Melanoma | 3 |
| Mesothelioma | 3 |
Trials
Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.